Immune system scientists and computational biologists are developing a new tool to investigate how the body fights disease.

First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and ...

May is Melanoma Awareness Month and Intermountain Health is unveiling an exciting new treatment program for Utahns with ...

Denise Broadie's family were overjoyed when she fought off breast cancer. After it came back two years later, she fought it ...

This year, the event highlighted eight-year-old Emily Buck, who is undergoing treatment for T-cell acute lymphoblastic ...

The potential role of vitamin D in preventing and treating colorectal cancer (CRC) has attracted growing research interest – especially as CRC rates are rising, particularly among younger adults. This ...

Patients with certain types of early stage cancer, particularly those affecting the gastrointestinal system, may be able to ...

Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a target the company described as a high interest immune cell target in immunology ...

A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery ...

A McGill University-led research collaboration has achieved a breakthrough in understanding how cancer spreads. A clinical ...

Cells have a mailing system of sorts. They can release tiny molecular balls, called extracellular vesicles (EVs), that ...

From distinguished researchers to our essential support staff, our community is united by a shared drive for discovery. We are dedicated to nurturing a wide range of talents at every career stage, ...